A complex element was the challenge of integrating this initiative in the company

As one of the main sponsors of the Olympic and Paralympic Games 2012 held in London in November 2009, the company announced a partnership with the University of King's College London to provide equipment and space organization and operation of a laboratory accredited by the World Anti -doping ups track (WADA).
GSK's mission is to improve quality of life so that people will be healthier, feel better ups track and live longer. One of the company's core values is transparency and accountability and transparency by integrating into how their business runs, GSK wants to base a relationship based on trust with all its stakeholders. GSK products are designed for healing patients, and research and development activities of the company is focusing on areas where the need for new drugs is most acute. Also, GSK acknowledged that there is always the possibility of uncontrolled use of drugs by some athletes to increase their sports performance.
The company realized that its role in the 2012 Olympic Games is an opportunity to share knowledge and expertise with the various stakeholders, and to do this as a part of anti-doping platform, created three partnerships:
1. GSK has created a partnership with the University of King's College London which provided space, equipment and expertise to anti-doping laboratory testing and ensure confidentiality for the Olympics. The lab was located ups track in the center of Harlow GSK research and development, its activities being undertaken ups track by university staff King's College. Through ups track this laboratory were analyzed ups track thousands of samples taken from athletes, 24 hours a day, throughout the Olympic Games and Paralympics.
2. Based on this partnership, in July 2011, GSK signed an historic partnership with the World Anti-Doping Agency for providing confidential information about drugs that are still under development and could be misused by athletes when they are released. Following this agreement, the drugs that were in the development stage were analyzed by company researchers to identify substances that could have the effect of improving athletic performance. Confidential scientific data about new drugs that will fit into the category described above, will be sent to WADA to develop methods to detect these substances.
3. University of King's College and GSK initiated a project called "scientists in sport" in which there were a number of free events across the UK, from April 2011 until the beginning of the Olympic ups track Games in 2012. These events students ups track in schools have the opportunity to spend a day in the university. The goal was to encourage children aged between 11 and 14 years to deepen their studies in science and pursue a career in this field, through conferences on sport and interactive workshops.
When a company is a partner of the Olympic Games, it is the attention of the general public, especially ups track if it is involved in the anti-doping that can affect the integrity of sports competitions this important exhibition. Therefore, GSK was essential to ensure that the working relationship with partners (University King's College London and WADA) will have a transparent approach. Although GSK collaborated separately with King's College and University WADA partnership with the two experts has allowed the company to confer both credibility and fairness of the entire project, and its involvement within it.
A complex element was the challenge of integrating this initiative in the company's commitment ups track to run a responsible business based values, achieved through collaboration with WADA challenge and commitment to mainstream transparency (related to increasing athletic performance) in the development of new products . The importance of this collaboration was highlighted and the statement made by John Fahey, the WADA president: "Our collaboration with the pharmaceutical industry is critical to staying one step ahead of athletes who are doping and have a level of increasing level of knowledge scientific ". Similarly, the company's involvement in the "Scientists in Sport 'demonstrates how GSK sought to create a sustainable legacy for science and sport after the 2012 Olympics.
Initiated